Pulsify Medical closes € 5.4 million second round of funding for portable ultrasound heart monitor patch
Pulsify Medical is developing wearable ultrasound patches to monitor vital human organs such as the heart.
LEUVEN, BELGIUM, May 4, 2021 /EINPresswire.com/ – Pulsify Medical is a digital medical technology company developing wearable ultrasound patches that will monitor vital organs in real time. The disruptive new technology will address a serious unmet need for continuous heart monitoring in ICUs, hospitals and homes around the world.
Today the company announced the second close of its first funding round, after raising an additional € 3.75 million in equity, bringing the Series A total to € 6.35 million. PMV, the Gemma Frisius fund and imec join the investors of the first Series A closing: imec.xpand, KU Leuven and University Hospitals Leuven. The company also obtained a non-dilutive research grant of 1.65 million euros from the Flanders Innovation and Entrepreneurship Administration (VLAIO).
Pulsify Medical continues to rely on unique, IP-protected technology, combining imec’s unique flexible ultrasound transducer technology with KU Leuven’s world-class expertise in cardiac ultrasound imaging algorithms to create the “Smart Patch”.
The Smart Patch: Changing the Lives of Heart Disease Patients
Pulsify Medical aims to create a smart and flexible “Smart Patch” containing thousands of sensors that monitor a variety of health parameters. The patch will be developed to reveal critical data about a patient’s heart health, such as changes in heart function. The information is relayed to both patients and physicians, to enable earlier medical intervention and the prevention of an adverse cardiac event in the event of an abnormality.
Chris Japp, Independent Chairman of the Board: “Pulsify Medical has assembled a team of experts whose mission is to transform heart care through real-time remote ultrasound monitoring. By combining new breakthroughs in ultrasound technology with the convenience and benefits of a portable medical device, Pulsify Medical has the potential to dramatically improve the lives of patients around the world. “
Diane Lejeune, Business Manager, MedTech and eHealth, PMV: “Thanks to first-rate technology and knowledge from strategic Flemish research centers, and a very experienced internal team, Pulsify Medical is working on building products aimed at changing the way the heart function is going. monitored, thus improving care and allowing shorter hospital stays. We are convinced that such goals will have a huge impact in ICUs and hospitals, not only in Flanders but around the world, and we are therefore delighted to join the group of investors supporting Pulsify Medical.
Iwan van Vijfeijken, CEO of Pulsify Medical: “Cardiovascular disease is the leading cause of death worldwide. Continuous heart monitoring and early warning can save lives and improve health, which is our biggest motivator at Pulsify Medical. I’m proud to say that we have made great strides since our debut in 2019: the team has optimized the algorithms that analyze the huge data sets obtained during monitoring, and the patch has been designed to adapt as much as possible. to patient mobility while precise monitoring of cardiac performance. This creates valuable information for patients and physicians that can be used to ensure patient safety. “
Steve Stoffels, Vice President of Technology, Pulsify Medical: “Ultrasound technology produces images with inimitable detail, revealing critical information about a patient’s health. However, ultrasound monitoring tools are not yet widely available in hospital intensive care units, let alone in ambulatory settings like the home. Pulsify Medical will change that, allowing for better monitoring of vital organs as well as a better patient experience. “
About Pulsify Medical
Pulsify Medical is a digital medical technology company developing wearable ultrasound patches to monitor vital organs in real time. The company was founded in 2019 as a spin-off of imec and KU Leuven (Medical Imaging Center). The Cardiac Patch from Pulsify Medical will be the first device to continuously and directly measure and monitor cardiac performance in real time in a hospital and at home. https://pulsify-medical.com/
PMV is an investment company that shapes the economic future of Flanders by funding promising companies from the very beginning to growth and internationalization. With more than € 1 billion in assets under management and led by experienced professionals, PMV offers tailor-made financial solutions to entrepreneurs with a solid business plan and a strong management team, including venture capital, loans and guarantees. You can find more information about PMV at www.pmv.eu.
About the Gemma Frisius Fund
Gemma Frisius Fund (GFF) is a seed capital fund, created in 1997 as a joint venture between KU Leuven, KBC Bank and BNP Paribas Fortis Private Equity. It combines the university’s research and technology transfer expertise with the financial and investment expertise of the two financial partners. The GFF provides seed capital in the early stages of development of innovative, research-based spin-off companies from all fields of technology and supports them in their growth process. For more information, go to https://lrd.kuleuven.be/en/spinoff/gemma-frisius-fund
The Agency for Innovation and Entrepreneurship (VLAIO) is a Flemish government organization for all entrepreneurs in Flanders. In 2016, the existing Enterprise Flanders branches and the business-led activities of IWT were merged into VLAIO. The research activities of the IWT have been taken over by the Flemish Research Council (FWO). VLAIO’s mission is to stimulate and support innovation and entrepreneurship and to contribute to a favorable business climate in Flanders.
VLAIO’s activities include stimulating growth and innovation by financially supporting businesses through grants, inspiring entrepreneurship by collaborating with different parties who can guide SMEs from (pre) start of growth at maturity or recovery; supporting clusters and strengthening environmental factors such as facilitating the development of business sectors. www.vlaio.be
Imec.xpand is a start-up and growth fund with a revolutionary approach to transforming hardware-driven nanotechnology innovation into successful global businesses. The fund is independently managed by a team of seasoned entrepreneurs, venture capitalists and business experts, targeting ambitious tech start-ups that meet all the criteria to become a successful and scalable company with potential. change the world, and where IMEC’s knowledge, expertise and infrastructure can play a critical role in their success. For more information on imec.xpand, please visit www.imecxpand.com.
Ann van gysel
+32 9218 71 97
write us here